» Articles » PMID: 21555955

Treatment of Irritable Bowel Syndrome with Saccharomyces Boulardii

Overview
Specialty Gastroenterology
Date 2011 May 11
PMID 21555955
Citations 2
Authors
Affiliations
Soon will be listed here.
Citing Articles

Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS.

Brun P, Scarpa M, Marchiori C, Sarasin G, Caputi V, Porzionato A PLoS One. 2017; 12(7):e0181863.

PMID: 28732069 PMC: 5521842. DOI: 10.1371/journal.pone.0181863.


Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders.

Kelesidis T, Pothoulakis C Therap Adv Gastroenterol. 2012; 5(2):111-25.

PMID: 22423260 PMC: 3296087. DOI: 10.1177/1756283X11428502.